|To the Editor: Cholesterol concerns explained|
|Written by William E. Feeman Jr., M.D.|
|Wednesday, 20 November 2013 10:25|
I do not regard the letter from Mr. Olds as hate mail. People can disagree about matters civilly, though the slaughter of Americans will continue as long as guns are freely available to anyone with the money to buy them. I and all of my brothers served in the Armed Forces to defend the right of free speech, as did my father, who built bridges for MacArthur in WWII. And by the way, I was not referring to the citizens of Wood County as low life's - I know many of them personally and know that they are the salt of the earth. I was referring to some of the people of the shoot-em-up Wild West a century ago.
The letter from Lloyd is another matter, and it speaks for itself. Lloyd refutes himself. However, I do want to clear up something. I never did a double-blind controlled trial on my patients. I did a presentation on the prevention of atherothrombotic disease (ATD) when I was in medical school at OSU in the late 1960s. That spurred my interest in ATD prevention. So I started reading and trying to prevent ATD while I was in the USAF and I continued to try to do the same when I got to BG in 1974. I knew that cholesterol was important, but it was only one of about 25 risk factors. So I collected risk factor data and when I found abnormalities, I offered treatment. Given the newness of this approach about 40 years ago, other physicians in BG were not receptive of what I was doing - after all, I was treating cholesterol at levels of 250 mg/dl, and they did not treat until levels of 300 mg/dl. (How things have changed! That's what comes of being the trailblazer, I guess.) Moreover, some patients were likewise often unwilling to take the treatment. My "study" involved a chart review - not a formal study - of the natural history of ATD and ATD risk factors. The world-famous Framingham Heart Study (FHS) taught us that the population of people who have ATD events differ from the population that does not have ATD events. So I looked at the risk factor constellations of those people who did and who did not have ATD events, just as FHS advised. All my work is based on this, and it gives a better perspective on the prediction of the population at risk of ATD than is available to university professors who do not have access to long-term databases. The work is observational, not anecdotal, just as that of FHS.
William E. Feeman Jr., M.D.
Front Page Stories
|Women still rare in local politics
03/13/2014 | KAREN NADLER COTA Sentinel Lifestyles Editor
File photo. Doris Herringshaw. (Photo: J.D. Pooley/Sentinel-Tribune) PERRYSBURG - [ ... ]
|Calamity days create chaos|
03/13/2014 | Sentinel-Tribune Staff
File photo. A student walks home from school during a winter storm. (Photo: Enoch Wu/Sen [ ... ]